Q2 2025 Holdings
Filed 2025-08-14 | 71 holdings | $100.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $15.0M | 323,358 | 14.9% |
| KLA Corporation(KLAC) | COM NEW | 482480100 | $14.2M | 15,848 | 14.1% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $4.9M | 67,200 | 4.9% |
| Ovintiv Inc(OVV) | COM | 69047Q102 | $4.1M | 107,500 | 4.1% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.1M | 187,800 | 4.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.9M | 30,940 | 3.9% |
| Phreesia Inc(PHR) | COM | 71944F106 | $3.3M | 114,700 | 3.2% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $2.7M | 451,019 | 2.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $2.7M | 48,000 | 2.6% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.4M | 210,000 | 2.4% |
| Elutia Inc(ELUT) | COM | 05479K106 | $2.3M | 1,159,059 | 2.3% |
| Castle Biosciences Inc(CSTL) | COM | 14843C105 | $2.3M | 110,600 | 2.2% |
| Quidelortho Corp | COM | 74838J101 | $2.1M | 72,548 | 2.1% |
| EQT Corporation(EQT) | COM | 26884L109 | $2.0M | 34,619 | 2.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $1.8M | 60,000 | 1.8% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $1.8M | 101,000 | 1.8% |
| Axogen Inc(AXGN) | COM | 05463X106 | $1.7M | 161,000 | 1.7% |
| Biodesix Inc | COM | 09075X108 | $1.6M | 5,736,113 | 1.6% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.5M | 103,000 | 1.5% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $1.5M | 310,930 | 1.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.4M | 50,000 | 1.4% |
| Masimo Corp(MASI) | COM | 574795100 | $1.4M | 8,280 | 1.4% |
| Uniqure NV(QURE) | SHS | N90064101 | $1.4M | 98,697 | 1.4% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $1.2M | 4,250 | 1.2% |
| Docgo Inc(DCGO) | COM | 256086109 | $1.2M | 764,062 | 1.2% |
| Treace Medical Concepts Inc(TMCI) | COM | 89455T109 | $1.0M | 176,947 | 1.0% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $870.6K | 178,768 | 0.9% |
| Kiniksa Pharmaceuticals LTD | COM | G5269C101 | $830.1K | 30,000 | 0.8% |
| Freeport-Mcmoran CL(FCX) | CL-B | 35671D857 | $781.7K | 18,033 | 0.8% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $757.4K | 67,000 | 0.8% |
| Structure Therapeutics Inc(GPCR) | SPONS ADR | 86366E106 | $746.6K | 36,000 | 0.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $694.9K | 16,000 | 0.7% |
| Outset Medical Inc(OMGBP) | COM | 690145107 | $664.4K | 34,584 | 0.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $657.3K | 21,000 | 0.7% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $654.5K | 18,000 | 0.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $626.3K | 6,000 | 0.6% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $570.8K | 134,000 | 0.6% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $566.7K | 16,000 | 0.6% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $562.8K | 60,000 | 0.6% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $558.5K | 26,000 | 0.6% |
| Immunome Inc(IMNM) | COM | 45257U108 | $558.0K | 60,000 | 0.6% |
| Xencor Inc(XNCR) | COM | 98401F105 | $550.2K | 70,000 | 0.5% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $520.2K | 10,000 | 0.5% |
| Pacific Biosciences Calif Inc(PACB) | COM | 69404D108 | $496.0K | 400,000 | 0.5% |
| Inhibrx Biosciences Inc(INBX) | COM | 45720N103 | $458.2K | 32,110 | 0.5% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $377.6K | 8,000 | 0.4% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $366.3K | 33,000 | 0.4% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $358.4K | 40,000 | 0.4% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $346.1K | 2,700 | 0.3% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $330.4K | 10,000 | 0.3% |